PEOPLE - Nanyang Management makes appointment:
This article was originally published in Clinica
Mike Hirshorn, one of Australia's most experienced medical technology commercialisation executives, has joined venture capital firm Nanyang Management. Mr Hirshorn is one of the founders of cochlear implant company Cochlear. He was also a founding director of sleep apnoea Nasdaq-listed Australian company Resmed and until recently was with Polartechnics, which is commercialising a cervical screening and melanoma detection device. With the addition of Mr Hirshorn, Nanyang, which manages St George Development Capital Fund and focuses on technology and specialised manufacturing, will also take an interest in medical devices.
You may also be interested in...
The head of the European Medicines Agency is nearing the end of his tenure. We consider Guido Rasi’s achievements over the past 10 years as well as the controversies that have arisen under his leadership – and report that sailing is likely to figure in his plans for life after the agency.
Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.